InflaRx N.V. IFRX
$ 2.06
0.98%
Annual report 2023
added 11-09-2024
Country |
Germany |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Niels C. Riedemann M.D., Ph.D. |
Employees in the company |
43 |
Shares |
- |
Market Cap[1] |
$ 152 M |
EBITDA (LTM) |
- |
P/E (LTM) |
-2.84 |
P/S (LTM) |
- |
EPS (LTM) |
-0.69 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.